Sign In
Buy BSX
$48.85
+1.16 (+2.43%)
At Close: Jun 04, 2026
Haemonetics (HAE) Up 3.2% Since Last Earnings Report: Can It Continue?
03:30pm, Friday, 09'th Sep 2022 Zacks Investment Research
Haemonetics (HAE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Where Boston Scientific Stands With Analysts
01:31pm, Friday, 09'th Sep 2022 Benzinga
Analysts have provided the following ratings for Boston Scientific (NYSE:BSX) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
5
3
0
0
0
Boston Scientific's (BSX) WATCHMAN FLX to Offer DAPT in the US
02:00pm, Wednesday, 07'th Sep 2022 Zacks Investment Research
Boston Scientific (BSX) to offer updated labeling for WATCHMAN FLX device after receiving FDA approval.
Trading The Top 10 Stocks From 40 Large Hedge Funds: Trading Update 9/4/2022
04:24am, Monday, 05'th Sep 2022 Seeking Alpha
A strategy selecting 10 of the 50 stocks, equally weighted, would have increased total return to 178.0%, an active return of 61.6% vs. SPY.
Boston Scientific (BSX) Grows Operationally Amid Macro Issues
03:04pm, Thursday, 01'st Sep 2022 Zacks Investment Research
In the Asia Pacific region, Boston Scientific (BSX) grows operationally with notable performance in Japan, India and the ASEAN countries.
Boston Scientific (BSX) Grows Operationally Amid Macro Issues
12:23pm, Thursday, 01'st Sep 2022
In the Asia Pacific region, Boston Scientific (BSX) grows operationally with notable performance in Japan, India and the ASEAN countries.
General Electric (GE), Boston Scientific Bond Over Heartcare
07:29pm, Wednesday, 24'th Aug 2022 Zacks Investment Research
General Electric's (GE) partnership deal will help the cardiac patients easily avail of heart care treatment.
Boston Scientific (BSX) Signs Obsidio-Acquisition Agreement
05:13pm, Wednesday, 17'th Aug 2022 Zacks Investment Research
Boston Scientific's (BSX) latest acquisition will add the FDA-approved GEM technology to its interventional oncology and embolization portfolio.
Boston Scientific (BSX) Signs Obsidio-Acquisition Agreement
02:18pm, Wednesday, 17'th Aug 2022
Boston Scientific's (BSX) latest acquisition will add the FDA-approved GEM technology to its interventional oncology and embolization portfolio.
Boston Scientific Announces Upcoming Conference Schedule
02:00pm, Tuesday, 16'th Aug 2022
MARLBOROUGH, Mass. , Aug. 16, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor events.
Coinbase Global, T-Mobile US And 2 Other Stocks Insiders Are Selling
11:50am, Tuesday, 16'th Aug 2022 Benzinga
U.S. crude oil futures traded lower this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades.
When insiders sell shares, it indicates their concern in the company’s pros
Boston Scientific: Strong Earnings Report, But Shares Are Not Cheap Yet
05:44pm, Tuesday, 09'th Aug 2022
The Health Care Sector ETF has beaten the S&P 500 this year, but there has been a recent relative weakness. One medical device company impressed the Street in late July with a bottom line beat and cou
The Zacks Analyst Blog Highlights Novartis, Duke Energy, Boston Scientific, Norfolk Southern and Cadence Design Systems
12:04pm, Monday, 01'st Aug 2022 Zacks Investment Research
Novartis, Duke Energy, Boston Scientific, Norfolk Southern and Cadence Design Systems are part of Zacks top Analyst Blog.
Belo Sun Announces the Retirement of Joe Milbourne, Vice President, Technical Services
09:00pm, Friday, 29'th Jul 2022 GlobeNewswire Inc.
TORONTO, July 29, 2022 (GLOBE NEWSWIRE) -- Belo Sun Mining Corp. (“Belo Sun” or the “Company”) (TSX: BSX; OTCQX: BSXGF) announces that Joe Milbourne, Vice President, Technical Services, wil
Top Analyst Reports for Novartis, Duke Energy & Boston Scientific
06:04pm, Friday, 29'th Jul 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including Novartis AG (NVS), Duke Energy Corporation (DUK), and Boston Scientific Corporation (BSX).
